These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 22237863)

  • 1. Expression and glucocorticoid-regulation of "Bam", a novel BH3-only transcript in acute lymphoblastic leukemia.
    Mansha M; Wasim M; Kofler A; Ploner C
    Mol Biol Rep; 2012 May; 39(5):6007-13. PubMed ID: 22237863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Repression of the BH3-only molecule PMAIP1/Noxa impairs glucocorticoid sensitivity of acute lymphoblastic leukemia cells.
    Ploner C; Rainer J; Lobenwein S; Geley S; Kofler R
    Apoptosis; 2009 Jun; 14(6):821-8. PubMed ID: 19421859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. "Bam," a novel glucocorticoid-induced BH3-only transcript from the BCL2L11/Bim locus, does not appear to be translated.
    Mansha M; Hussain A; Kofler A; Grubbauer C; Goetsch K; Ploner C; Kofler R
    Leuk Lymphoma; 2013 Feb; 54(2):353-8. PubMed ID: 22762551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The BCL2 rheostat in glucocorticoid-induced apoptosis of acute lymphoblastic leukemia.
    Ploner C; Rainer J; Niederegger H; Eduardoff M; Villunger A; Geley S; Kofler R
    Leukemia; 2008 Feb; 22(2):370-7. PubMed ID: 18046449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucocorticoid-mediated BIM induction and apoptosis are regulated by Runx2 and c-Jun in leukemia cells.
    Heidari N; Miller AV; Hicks MA; Marking CB; Harada H
    Cell Death Dis; 2012 Jul; 3(7):e349. PubMed ID: 22825467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opposing regulation of BIM and BCL2 controls glucocorticoid-induced apoptosis of pediatric acute lymphoblastic leukemia cells.
    Jing D; Bhadri VA; Beck D; Thoms JA; Yakob NA; Wong JW; Knezevic K; Pimanda JE; Lock RB
    Blood; 2015 Jan; 125(2):273-83. PubMed ID: 25336632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of miR17 pathway in glucocorticoid-induced cell death in pediatric acute lymphoblastic leukemia.
    Harada M; Pokrovskaja-Tamm K; Söderhäll S; Heyman M; Grander D; Corcoran M
    Leuk Lymphoma; 2012 Oct; 53(10):2041-50. PubMed ID: 22475310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bim polymorphisms: influence on function and response to treatment in children with acute lymphoblastic leukemia.
    Gagné V; Rousseau J; Labuda M; Sharif-Askari B; Brukner I; Laverdière C; Ceppi F; Sallan SE; Silverman LB; Neuberg D; Kutok JL; Sinnett D; Krajinovic M
    Clin Cancer Res; 2013 Sep; 19(18):5240-9. PubMed ID: 23908358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucocorticoid resistance in chronic lymphocytic leukaemia is associated with a failure of upregulated Bim/Bcl-2 complexes to activate Bax and Bak.
    Melarangi T; Zhuang J; Lin K; Rockliffe N; Bosanquet AG; Oates M; Slupsky JR; Pettitt AR
    Cell Death Dis; 2012 Aug; 3(8):e372. PubMed ID: 22898870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pro-apoptotic protein BIM in apoptosis of glucocorticoid-sensitive and -resistant acute lymphoblastic leukemia CEM cells.
    Zhao YN; Guo X; Ma ZG; Gu L; Ge J; Li Q
    Med Oncol; 2011 Dec; 28(4):1609-17. PubMed ID: 20697841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The BH3 alpha-helical mimic BH3-M6 disrupts Bcl-X(L), Bcl-2, and MCL-1 protein-protein interactions with Bax, Bak, Bad, or Bim and induces apoptosis in a Bax- and Bim-dependent manner.
    Kazi A; Sun J; Doi K; Sung SS; Takahashi Y; Yin H; Rodriguez JM; Becerril J; Berndt N; Hamilton AD; Wang HG; Sebti SM
    J Biol Chem; 2011 Mar; 286(11):9382-92. PubMed ID: 21148306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Erg and AP-1 as determinants of glucocorticoid response in acute lymphoblastic leukemia.
    Chen DW; Saha V; Liu JZ; Schwartz JM; Krstic-Demonacos M
    Oncogene; 2013 Jun; 32(25):3039-48. PubMed ID: 22869147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Akt requires glucose metabolism to suppress puma expression and prevent apoptosis of leukemic T cells.
    Coloff JL; Mason EF; Altman BJ; Gerriets VA; Liu T; Nichols AN; Zhao Y; Wofford JA; Jacobs SR; Ilkayeva O; Garrison SP; Zambetti GP; Rathmell JC
    J Biol Chem; 2011 Feb; 286(7):5921-33. PubMed ID: 21159778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of glucocorticoid-induced apoptosis by targeting the major splice variants of BIM mRNA with small interfering RNA and short hairpin RNA.
    Abrams MT; Robertson NM; Yoon K; Wickstrom E
    J Biol Chem; 2004 Dec; 279(53):55809-17. PubMed ID: 15509554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MEK inhibitors potentiate dexamethasone lethality in acute lymphoblastic leukemia cells through the pro-apoptotic molecule BIM.
    Rambal AA; Panaguiton ZL; Kramer L; Grant S; Harada H
    Leukemia; 2009 Oct; 23(10):1744-54. PubMed ID: 19404317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PLZF/ZBTB16, a glucocorticoid response gene in acute lymphoblastic leukemia, interferes with glucocorticoid-induced apoptosis.
    Wasim M; Carlet M; Mansha M; Greil R; Ploner C; Trockenbacher A; Rainer J; Kofler R
    J Steroid Biochem Mol Biol; 2010 Jun; 120(4-5):218-27. PubMed ID: 20435142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oncogenic kit triggers Shp2/Erk1/2 pathway to down-regulate the pro-apoptotic protein Bim and to promote apoptosis resistance in leukemic cells.
    Selimoglu-Buet D; Gallais I; Denis N; Guillouf C; Moreau-Gachelin F
    PLoS One; 2012; 7(11):e49052. PubMed ID: 23145067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bim is the key mediator of glucocorticoid-induced apoptosis and of its potentiation by rapamycin in human myeloma cells.
    López-Royuela N; Balsas P; Galán-Malo P; Anel A; Marzo I; Naval J
    Biochim Biophys Acta; 2010 Feb; 1803(2):311-22. PubMed ID: 19914305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. c-Myc dependent expression of pro-apoptotic Bim renders HER2-overexpressing breast cancer cells dependent on anti-apoptotic Mcl-1.
    Campone M; Noël B; Couriaud C; Grau M; Guillemin Y; Gautier F; Gouraud W; Charbonnel C; Campion L; Jézéquel P; Braun F; Barré B; Coqueret O; Barillé-Nion S; Juin P
    Mol Cancer; 2011 Sep; 10():110. PubMed ID: 21899728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 2-deoxyglucose-induced toxicity is regulated by Bcl-2 family members and is enhanced by antagonizing Bcl-2 in lymphoma cell lines.
    Zagorodna O; Martin SM; Rutkowski DT; Kuwana T; Spitz DR; Knudson CM
    Oncogene; 2012 May; 31(22):2738-49. PubMed ID: 21986940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.